Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Tasigna is the first and only second-generation tyrosine kinase inhibitor approved in the EU ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email